Firmus pulled a $44 billion float. Strip away the headlines and it’s a lesson in capital raising fundamentals.

Written By Derek Thomson

Go to Home page

  • Deal complexity, not deal size, determines the experience you need.
  • Market volatility is a risk to plan for, not an excuse after the fact.
  • Transparency is how you keep credibility. Lose one and you lose both.
  • Investors fund the team’s ability to deliver, not just the vision.
  • Governance has to be on the founder’s agenda, because it’s on the investor’s.

Firmus withdrew its ASX listing application on Friday morning, citing market volatility. It had set its shares at $11 to raise $7.1 billion and was two weeks from listing at a $43.7 billion market capitalisation. That would have been the second largest float in Australian history, behind Telstra in 1997.

The easy read is that the AI bubble is wobbling. As James Thomson argued in the AFR’s Chanticleer column, the evidence doesn’t support that. Nvidia, the S&P 500 and the Nasdaq all hit record highs in the same week. In his view, global investors simply decided Firmus wasn’t special enough at the price.

I’d go further. Strip away the exterior attributes of this deal. Set aside its size, the second largest float since Telstra. Set aside the history of the founders, which has drawn as much commentary as the business itself. Set aside the fact that it’s an AI and data centre play, a sector that carries its own magnetism for investors and its own set of risks. What’s left is a case study in the raw fundamentals of capital raising, tested in a market that has become acutely wary of execution risk. Five lessons stand out.

Size isn’t the hard part. Complexity is.

One of the fundamental elements of building a business is developing a strategy for a complex market, and then selling it to the people you need to fund it. Firmus had no shortage of big-deal experience, with Morgan Stanley, Bank of America, JPMorgan and Morgans Financial as joint lead managers. But like many new business concepts seeking capital, it had to sell its strategy through several layers of complexity at once.

Defending the valuation. New concepts rarely have the history to anchor a price. Firmus was worth $1.85 billion a year ago and went to market at $43.7 billion.

Retaining and delivering for partners. Early-stage businesses often borrow credibility from partners. Firmus leaned on Nvidia, OpenAI, Meta and CDC, and the CDC partnership fell away mid-bookbuild.

Attracting offshore investors. Large raises outgrow the local market. Firmus needed overseas institutions, and that demand didn’t arrive as expected.

Navigating a volatile, crowded market. New sectors attract competitors fast. Firmus was one of around 200 neoclouds, in a week when CoreWeave fell 12 per cent.

Managing social licence and regulation. Physical infrastructure brings communities and regulators into the deal. Firmus faced local opposition in Tasmania and approvals across several countries.

A strategy that can’t be explained convincingly across all five won’t raise capital, however compelling the vision. Selling it takes people who have done something structurally similar and know how to manage investor sentiment through a live book. Experience with deal size doesn’t solve for that.

Volatility is a risk to plan for, not an excuse after the fact

Markets were certainly noisy. The Nasdaq 100 fell 1.4 per cent on Thursday night after reports that OpenAI’s recurring revenue was well below earlier figures. But volatility in an AI raise in late 2026 is the base case, not a surprise.

A deal of this scale needs more than a base case. It needs fully built scenarios for procuring all the capital required if the base case doesn’t deliver: alternative venues, alternative structures, alternative timetables, each costed and ready to execute. Firmus’s process looked brittle by comparison. The bankers reportedly tested a price as low as $8.25 to find enough support, and Firmus ultimately said a lower price wouldn’t reflect its growth potential. When the only visible contingency is withdrawal, investors price that fragility in from day one.

The Nasdaq option shows what was missing. Firmus has since flagged a US listing next year. From the outside, it reads like a plan conjured in the surprise of failure. It could instead have been one of a range of options set out for investors upfront, to be used if volatility derailed the ASX listing. Being prepared in that way tells investors the founders understand they can’t control all aspects of the market, but have mitigated the risk to protect committed funding. That’s what gives investors the confidence to commit in the first place.

Transparency is how you keep credibility. Lose one and you lose both.

This is the lesson I’d underline twice. In a capital raise, credibility is the currency. Investors are asked to trust your numbers and your judgement before they can test them. Transparency is how you earn that trust and keep it under pressure.

Firmus’s problem was not that its facts were unmanageable. It was how investors learned them. They found out mid-process that escrow terms would let existing holders sell more than half the stock from day one. Orders were pulled after the end of the CDC partnership was revealed by CDC’s founder on a podcast, not by Firmus. A November 30 deadline would hand later investors a larger equity share if the listing slipped. And Firmus had already postponed a planned ASX listing earlier this year after a lukewarm response from investors.

Each fact could have been framed and priced if the company had put it on the table first. Arriving late, or from a third party, they made investors ask what else they hadn’t been told. Once that question is in the room, every other claim gets discounted. The same goes for demand signals. Underwriters had claimed interest well above the $7.1 billion offer size, and the market was assured twice early in the week that the deal would proceed. Three days later it was gone.

Tell the investors you want on board exactly where you are in the raise: what’s committed, by whom, on what terms, and how much more you need. They’ll find out anyway. Colouring the story doesn’t buy time. It spends credibility you’ll need for the next raise.

Investors fund the team’s ability to deliver, not just the vision

Every raise asks investors to fund something that doesn’t exist yet. What they’re really underwriting is the people who will build it.

Firmus asked investors to back a $51 billion build of five AI data centres over two years. Bloomberg reported that only about 5% of the capacity it has sold is built and running, against roughly 25% at NextDC. That gap is where management credibility does its work, and investors found it lacking. Reuters reported prospective investors pointing to an unproven track record, and ShareCafe reported fund managers citing a management team without demonstrated delivery.

Founders don’t need to have delivered their full vision before raising capital. No growth company has. But investors need to see a senior team with the skills to cover every commercial aspect of execution: project finance at scale, large construction delivery, hyperscale customer contracts, multi-jurisdiction approvals, and a balance sheet carrying tens of billions in debt. If the founders don’t bring that track record, build a team around them that does, and make it visible well before the book opens.

Governance has to be on the founder’s agenda, because it’s on the investor’s

In private markets, capital often follows the founders. Firmus had a compelling vision and marquee backers, with Nvidia, Blackstone and Coatue on the register. Once you ask institutions for billions, the question changes. Investors stop asking whether the founders are impressive and start asking who holds them to account.

Governance adequate for a growing private company is rarely adequate for one seeking a $43.7 billion public valuation. Investors want independent oversight, disciplined capital allocation, credible assumptions and directors prepared to challenge management. They want a board that understands project finance, construction, customer concentration, energy, regulation and balance sheet exposure. And they want founder and shareholder arrangements, like the escrow terms and dilution triggers that surfaced mid-week, resolved or explained before launch.

Founders who treat governance as a listing checklist will find investors treating it as a pricing input. The board must be credible to the investors being asked to fund the business. If governance is high on the investor’s agenda, it needs to be higher on the founder’s.

The cost of skipping the fundamentals

Firmus may well come back. It reportedly retains the support of its customers and Nvidia, and debt markets remain open to it. But the cost of a failed raise doesn’t end when the book closes.

In a week, a $43.7 billion listing became a scramble for private capital. An Australian development partnership was gone. Maas Group, a 3.2% shareholder, fell as much as 30%, erasing around A$517 million. The November 30 dilution trigger now hangs over early holders, including the founders. And Firmus must repair its reputation while it raises, so its next round of capital, debt included, will almost certainly cost more.

That’s the real price of avoiding the fundamentals. Lost partners, damaged shareholders, a weaker negotiating position and a credibility deficit that follows the business into every future investor conversation. In capital markets, reputation is built slowly and spent very quickly.

For boards and management teams preparing their own raises, the question worth asking isn’t whether investor appetite is still there. It clearly is. It’s whether your strategy, your team, your board and your disclosures would survive a discerning investor in a volatile week, with every fact you’d prefer to explain later already on the table. Take away the size, the founders and the sector, and that’s the test Firmus faced. It’s also the test Firmus still faces. Whether the next raise comes from private markets or a Nasdaq listing, the same investors will be asking the same questions, and they’ll remember how the last ones were answered.

#CapitalMarkets #IPO #CorporateGovernance #CapitalRaising #ExecutionRisk

References

Share article on

Leave a Reply

Discover more from Derek Thomson

Subscribe now to keep reading and get access to the full archive.

Continue reading